Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Active Implantable Medical Devices Market: Leading Players to Focus on Involving Into Partnerships With Hospitals and Dermatologists for Greater Visibility, Says TMR

Transparency Market Research
Posted on: 20 Feb 18
Global Active Implantable Medical Devices Market: Leading Players to Focus on Involving Into Partnerships With Hospitals and Dermatologists for Greater Visibility, Says TMR

PR Newswire

ALBANY, New York, February 20, 2018

ALBANY, New York, February 20, 2018 /PRNewswire/ --

According to the research report, the opportunity in the global active implantable medical devices market is likely to expand at a CAGR of 4.40% over the period from 2017 to 2025 and reach a value of US$20.73 bn by the end of the forecast period. Implantable cardioverter defibrillators (ICDs) are registering a relatively greater demand and are anticipated to continue doing so over the forthcoming years. Hospitals, ambulatory surgery centers (ASCs), and specialty clinics have surfaced as the key end users of active implantable medical devices across the world. Hospitals, among these, are expected to report a higher uptake of these device in the years to come. In terms of the region, North America led the global market in 2016 with a share of 33.5%. Researchers project the scenario to remain more or less the same over the forthcoming years, notes the market study.

Get PDF Brochure for Research Insights at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=37823

Increasing prevalence of Cardiovascular and Neurological Disorders to Boost Demand 

"The increasing prevalence of cardiovascular and neurological disorders among people across the world is the main factor that has been influencing the growth of the global market for active implantable medical devices," says the author of this research study. Apart from this, the market's growth is also influenced by frequent product approvals and continual product launches. Companies are introducing innovative and novel products so as to maintain competitive advantage, carve new markets and lay foundation for sustained business growth, states the research report.

Challenges Regarding Usage of Active Implantable Medical Devices to Hamper Growth 

On the flip side, challenges related to the usage of active implantable medical devices, such as device failure and concerns related to cybersecurity, may hamper the growth of the worldwide market for active implantable medical devices in the years to come. However, the rising healthcare expenditure associated with the increasing number of patients with cardiovascular diseases (CVDs) and neurological disorders is likely to fuel the demand for active implantable medical devices, supporting the growth of this market over the next few years, reports the market study.

Request a Custom Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=37823

A number of leading players in the global active implantable medical devices are investing extensively in the research and development of their new implants, finds a new research report by Transparency Market Research (TMR). These players are also involving into partnerships with hospitals and dermatologists to increase the sales of their products. Boston Scientific Corp., Abbott Laboratories, Medtronic Plc, Sonova Holding AG, LivaNova Plc, BIOTRONIK SE & Co. KG, Cochlear Ltd., William Demant Holding A/S, Nurotron Biotechnology Co. Ltd., and MED-EL Medical Electronics are some of the leading players in the global market for active implantable medical devices. These players are expected to use innovative strategies to widen their product portfolio in order to improve their market position over the next few years, states the research report.

Purchase your own copy of Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=37823&ltype=S

The review is based on a report by Transparency Market Research (TMR), titled "Active Implantable Medical Devices Market (Product - Cardiac Pacemaker, Implantable Cardioverter Defibrillators (ICD), Nerve Stimulators, Insertable Cardiac Monitor (Implantable Monitoring Devices), Cochlear Implants, and Ventricular Assist Devices (VAD); Procedure - Cardiovascular Implants, Neurological Implants, and Hearing Implants; End User - Hospitals, Ambulatory Surgery Centers, and Specialty Clinics) - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast, 2017-2025."

Key Takeaways 

  • Implantable cardioverter defibrillators (ICDs) are registering a relatively greater demand.
  • Hospitals, ambulatory surgery centers (ASCs), and specialty clinics have surfaced as the key end users of active implantable medical devices.

The global active implantable medical devices market has been segmented as follows:

By Product 

  • Cardiac Pacemaker
    • Single Chamber Pacemaker
    • Dual Chamber Pacemaker
    • Others
  • Implantable Cardioverter Defibrillators (ICD)
    • Transvenous Implantable Cardioverter Defibrillators
    • Subcutaneous Implantable Cardioverter Defibrillators
  • Nerve Stimulators
  • Cochlear Implants
  • Ventricular Assist Devices (VAD)
  • Insertable Cardiac Monitor (Implantable Monitoring Devices)

By Procedure 

  • Cardiovascular Implants
  • Neurological Implants
  • Hearing Implants
  • Others

By End User 

  • Hospitals
  • Ambulatory Surgery Centers
  • Specialty Clinics

By Geography 

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Israel
    • GCC countries
    • Rest of MEA

Popular Research Reports by TMR: 

About Us 

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Research Blog: https://theglobalhealthnews.com/

SOURCE Transparency Market Research

PR Newswire
www.prnewswire.com

Last updated on: 20/02/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.